We investigated the clinical, arthroscopic and biomechanical outcome of transplanting autologous chondrocytes, cultured in atelocollagen gel, for the treatment of full-thickness defects of cartilage in 28 knees (26 patients) over a minimum period of 25 months.
Osteochondral allograft (OCA) transplantation is a clinically and cost-effective option for symptomatic cartilage defects. In 2017 we initiated a program for OCA transplantation for complex chondral and osteochondral defects as a UK tertiary referral centre. To characterise the complications, re-operation rate, graft survivorship and clinical outcomes of knee OCA transplantation.Abstract
Background
Aim
Autologous chondrocyte implantation is a NICE approved intervention however it involves the morbidity of two operations, a prolonged rehabilitation and substantial healthcare costs. This study describes a novel, one-step, bone marrow (BM) derived mesenchymal stem cell (MSC) transplantation technique for treating knee osteochondral lesions and presents our prospective clinical study investigating the success of this technique in 206 lesions over a 5 year period. The surgical technique involves harvesting BM from patients’ anterior superior iliac spines, centrifugation to isolate MSCs and seeding into a type 1 collagen scaffold (SyngenitTM Biomatrix). Autologous fibrin glue is used to secure the scaffold into the defect. Inclusion criteria included patients aged 15 – 55 years old with symptomatic osteochondral lesions >1cm2. Exclusion criteria included patients with ligament instability, uncorrected alignment, inflammatory arthropathy and a Body Mass Index >35 kg/m2. Outcome measures included the Modified Cincinnati Knee Rating System (MCKRS), complications and reoperations.Abstract
Background
Methodology
Subtotal or total meniscectomy in the medial or lateral compartment
of the knee results in a high risk of future osteoarthritis. Meniscal
allograft transplantation has been performed for over thirty years
with the scientifically plausible hypothesis that it functions in
a similar way to a native meniscus. It is thought that a meniscal
allograft transplant has a chondroprotective effect, reducing symptoms
and the long-term risk of osteoarthritis. However, this hypothesis has
never been tested in a high-quality study on human participants.
This study aims to address this shortfall by performing a pilot
randomised controlled trial within the context of a comprehensive
cohort study design. Patients will be randomised to receive either meniscal transplant
or a non-operative, personalised knee therapy program. MRIs will
be performed every four months for one year. The primary endpoint
is the mean change in cartilage volume in the weight-bearing area
of the knee at one year post intervention. Secondary outcome measures
include the mean change in cartilage thickness, T2 maps, patient-reported
outcome measures, health economics assessment and complications.Objectives
Methods
We compared extrusion of the allograft after
medial and lateral meniscal allograft transplantation and examined
the correlation between the extent of extrusion and the clinical
outcome. A total of 73 lateral and 26 medial meniscus allografts
were evaluated by MRI at a mean of 32 months (24 to 59) in 99 patients
(67 men, 32 women) with a mean age of 35 years (21 to 52). The absolute
values and the proportional widths of extruded menisci as a percentage were
measured in coronal images that showed maximum extrusion. Functional
assessments were performed using Lysholm scores. The mean extrusion
was 4.7 mm (1.8 to 7.7) for lateral menisci and 2.9 mm (1.2 to 6.5)
for medial menisci (p <
0.001), and the mean percentage extrusions
were 52.0% (23.8% to 81.8%) and 31.2% (11.6% to 63.4%), respectively
(p <
0.001). Mean Lysholm scores increased significantly from
49.0 (10 to 83) pre-operatively to 86.6 (33 to 99) at final follow-up
for lateral menisci (p = 0.001) and from 50.9 (15 to 88) to 88.3
(32 to 100) for medial menisci (p <
0.001). The final mean Lysholm
scores were similar in the two groups (p = 0.312). Furthermore,
Lysholm scores were not found to be correlated with degree of extrusion
(p = 0.242). Thus, transplanted lateral menisci extrude more significantly
than transplanted medial menisci. However, the clinical outcome
after meniscal transplantation was not found to be adversely affected
by extrusion of the allograft.
The aim of this study was to report the outcome of femoral condylar fresh osteochondral allografts (FOCA) with concomitant realignment osteotomy with a focus on graft survivorship, complications, reoperation, and function. We identified 60 patients (16 women, 44 men) who underwent unipolar femoral condylar FOCA with concomitant realignment between 1972 and 2012. The mean age of the patients was 28.9 years (10 to 62) and the mean follow-up was 11.4 years (2 to 35). Failure was defined as conversion to total knee arthroplasty, revision allograft, or graft removal. Clinical outcome was evaluated using the modified Hospital for Special Surgery (mHSS) score.Aims
Patients and Methods